Intern, R&D Systems Technology Group

Roche

Jan 26, 2024

Applications are closed

Internship
Full-time
Off-cycle Internship
Research & Development
Science
San Francisco

Requirements

Master’s and PhD students preferred.
Required major: Mechanical Engineering, Bioengineering, Biomedical Engineering, or a closely related discipline
GPA of at least 3.5
Required Skills:
Experience with rapid prototyping technologies and basic shop tools
Excellent communication, collaboration, organizational and interpersonal skills
Works with integrity and takes ownership of their work
Preferred Qualifications:
Strong drive for problem solving skills for multidisciplinary challenges
Naturally curious and hungry to learn new technical skills and concepts
Experience with microfluidic device fabrication

Responsibilities

As an intern, you will have the opportunity to assist our team of engineers in the development and testing of proof-of-concept devices and fixtures related to our innovative platforms. This role offers hands-on experience in an interdisciplinary setting, encompassing a range of responsibilities such as testing and characterizing components, sub-systems, and fixtures. Additionally, you will be involved in data analysis, report writing, and presenting results. You may also contribute to projects involving the development of microfluidic device fabrication methods, device integration, and characterization. Collaboration with fellow engineers and scientists will be a key aspect, as you work closely together on integration efforts and verification activities.

Roche

Doing now what patients need next.

Science & Healthcare

Industry

10,001+

Employees

1896

Founded Year

Mission & Purpose

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).